Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,423 | 14,523 | 27,769 | 46,492 | 48,047 |
| Marketable Securities | 24,373 | 24,777 | 15,956 | 20 | 20 |
| Receivables | 223 | 378 | 923 | 868 | 1,270 |
| Other current assets | 3,889 | 3,555 | 3,695 | 3,269 | 4,088 |
| TOTAL | $39,486 | $43,738 | $48,956 | $51,317 | $54,069 |
| Non-Current Assets | |||||
| Intangibles | 20,191 | 20,636 | 21,024 | 20,910 | 20,934 |
| Other Non-Current Assets | 983 | 1,005 | 1,151 | 1,144 | 1,146 |
| TOTAL | $21,174 | $21,641 | $22,174 | $22,055 | $22,080 |
| Total Assets | $60,660 | $65,379 | $71,130 | $73,372 | $76,149 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,391 | 1,785 | 2,247 | 1,809 | 1,273 |
| TOTAL | $3,653 | $2,984 | $3,745 | $2,865 | $2,846 |
| Non-Current Liabilities | |||||
| TOTAL | $21,171 | $21,638 | $22,044 | $21,925 | $21,950 |
| Total Liabilities | $24,823 | $24,622 | $25,789 | $24,791 | $24,796 |
| Shareholders' Equity | |||||
| Common Shares | 107,016 | 109,297 | 111,331 | 109,555 | 109,596 |
| Retained earnings | -93,956 | -91,268 | -88,569 | -83,934 | -80,177 |
| Other shareholders' equity | 7,864 | 8,038 | 8,189 | 8,145 | 8,154 |
| TOTAL | $35,837 | $40,756 | $45,341 | $48,581 | $51,352 |
| Total Liabilities And Equity | $60,660 | $65,379 | $71,130 | $73,372 | $76,149 |